Bile Duct Cancer News and Research

Latest Bile Duct Cancer News and Research

GW researcher receives grant to examine link between liver fluke infection and bile duct cancer

Liver fluke infection is a major public health problem affecting more than 10 million people in Southeast Asia, particularly in Thailand and Laos. Infection has been strongly linked to cholangiocarcinoma, or bile duct cancer, an uncommon but aggressive form of cancer.

5 Sep 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test.

10 May 2018

‘Rapid autopsy’ programs seek clues to cancer within hours of death

After Keith Beck died of bile duct cancer last year, family members said more than 900 people showed up to pay respects to the popular athletic director at the University of Findlay in northwestern Ohio.

26 Apr 2018

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Kandice Fogle, 43, had just moved to Houston when she began experiencing pain in her back and groin. After undergoing a CT scan, doctors found a large mass in her liver. A biopsy confirmed that she had intrahepatic cholangiocarcinoma, more commonly known as bile duct cancer.

11 Apr 2018

Investigating new cancer therapy candidates with live-cell imaging

There are two main things that we've worked on in the lab as regards to drug studies. One is identifying new combinations of drugs, and working on why a combination of drugs should work better than each alone.

From Sartorius 16 Oct 2017

Negocios Now names Loyola Medicine neurologist among 50 most influential Latinos in Chicago

Loyola Medicine neurologist José Biller, MD, has been named to Negocios Now's list of the 50 Most Influential Latinos in the Chicago Area.

2 Aug 2017

Investigational compound inhibits cancer-specific mutations in mice

Many malignancies develop as a result of genetic alterations in individual cells. These gene mutations often cause altered proteins that give new, growth-promoting properties to the cell.

30 May 2017

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy--exercise.

6 Jun 2016

High levels of p62 protein in liver linked to cancer recurrence

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples are strongly associated with cancer recurrence and reduced patient survival.

20 May 2016

Regular aspirin use may help reduce risk of bile duct cancer

Regular use of aspirin was linked with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, in a recent study. The findings, which are published in the journal Hepatology, indicate that additional research on the potential of aspirin for preventing bile duct cancer is warranted.

27 Apr 2016

Aspirin use linked with reduced risk of developing bile duct cancer

A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology.

20 Apr 2016

New therapy strategy for liver disease shows initial measureable success with norUrso

The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso).

19 Apr 2016

CCF approved for Eugene Washington Engagement Award by PCORI to support upcoming conference

The Cholangiocarcinoma Foundation has been approved for a Eugene Washington Engagement Award by the Patient-Centered Outcomes Research Institute to support its 2016 Annual Conference on February 3-6 in Salt Lake City.

26 Jan 2016

Researchers develop multiplexed screening approach to study cancer development in mice

In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their cancer-causing roles and determining which combinations of genes cooperate to cause liver cancer.

27 Oct 2015

Cancer-causing parasitic worm may help patients recover from wounds, say JCU scientists

It's short, ugly and deadly. But James Cook University scientists have found a cancer-causing, parasitic worm could help patients recover from their wounds.

22 Oct 2015

MACC1 gene can help predict better treatment options for patients with Klatskin carcinoma

Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not, because their risk of cancer recurrence is too high? With the oncogene MACC1 as a biomarker, physicians for the first time have a tool to decide which treatment option is best for patients with Klatskin carcinoma, one type of bile duct cancer.

1 Sep 2015

New class of experimental drug could help patients with bile duct cancer

Patients with bile duct cancer could be helped by a new class of experimental drug, a study has shown.

18 Feb 2015

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer.

2 Feb 2015

Concordia Healthcare reports record revenues of 147% in third quarter 2014

Concordia Healthcare Corp. ("Concordia" or the "Company"), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced its financial and operational results for the three and nine months ended September 30, 2014.

14 Nov 2014

Bile Duct Cancer News and Research

Latest Bile Duct Cancer News and Research

GW researcher receives grant to examine link between liver fluke infection and bile duct cancer

Clinical trial targets metastatic colorectal cancer with new combination therapy

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

‘Rapid autopsy’ programs seek clues to cancer within hours of death

Study offers new hope for patients with intrahepatic cholangiocarcinoma

Investigating new cancer therapy candidates with live-cell imaging

Negocios Now names Loyola Medicine neurologist among 50 most influential Latinos in Chicago

Investigational compound inhibits cancer-specific mutations in mice

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

High levels of p62 protein in liver linked to cancer recurrence

Regular aspirin use may help reduce risk of bile duct cancer

Aspirin use linked with reduced risk of developing bile duct cancer

New therapy strategy for liver disease shows initial measureable success with norUrso

CCF approved for Eugene Washington Engagement Award by PCORI to support upcoming conference

Researchers develop multiplexed screening approach to study cancer development in mice

Cancer-causing parasitic worm may help patients recover from wounds, say JCU scientists

MACC1 gene can help predict better treatment options for patients with Klatskin carcinoma

New class of experimental drug could help patients with bile duct cancer

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Concordia Healthcare reports record revenues of 147% in third quarter 2014

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Bile Duct Cancer News and Research

Latest Bile Duct Cancer News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in